Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1984 2
1986 2
1987 1
1988 2
1989 6
1990 1
1991 1
1992 7
1993 4
1994 8
1995 7
1996 9
1997 9
1998 4
1999 6
2000 8
2001 8
2002 10
2003 7
2004 13
2005 15
2006 24
2007 19
2008 21
2009 23
2010 20
2011 32
2012 41
2013 56
2014 56
2015 79
2016 84
2017 81
2018 127
2019 117
2020 145
2021 152
2022 136
Text availability
Article attribute
Article type
Publication date

Search Results

1,216 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of CD19 CAR T constructed with a new anti-CD19 chimeric antigen receptor in relapsed or refractory acute lymphoblastic leukemia.
Gu R, Liu F, Zou D, Xu Y, Lu Y, Liu B, Liu W, Chen X, Liu K, Guo Y, Gong X, Lv R, Chen X, Zhou C, Zhong M, Wang H, Wei H, Mi Y, Qiu L, Lv L, Wang M, Wang Y, Zhu X, Wang J. Gu R, et al. J Hematol Oncol. 2020 Sep 7;13(1):122. doi: 10.1186/s13045-020-00953-8. J Hematol Oncol. 2020. PMID: 32894185 Free PMC article. Clinical Trial.
Reward-driven attention alters perceived salience.
Qin N, Gu R, Xue J, Chen C, Zhang M. Qin N, et al. Among authors: gu r. J Vis. 2021 Jan 4;21(1):7. doi: 10.1167/jov.21.1.7. J Vis. 2021. PMID: 33433602 Free PMC article.
1,216 results